Useful links
Thyroid Cancer Research Group
Expanding translational research in thyroid cancer therapeutics
Our research group is comprised of surgeons, physicians, scientists, pathologists, clinical trial nurses, patient representative who meet to prioritise and develop research in the diagnosis and management of thyroid cancer.
Our researchers have demonstrated high impact publications and are recipients of NHMRC, Cancer Institute, Lincoln Centre, Cancer Council, University of Sydney Research Fund, Ramsay Health, Rebecca Cooper Foundation, Avant Foundation, Phaeo/Para Alliance and HCF Research Foundation grants.
Our senior researchers have outstanding H-indexes and demonstrate a >200+ publication list.
Research themes
Our aim is to establish a comprehensive personalised approach to thyroid cancer management across the full spectrum of the disease, utilising evidence-based algorithms.
Our overarching goal aims to prevent the unnecessary overtreatment of low risk thyroid cancer (minimising unnecessary harm) and to develop a personalised genomic and clinicopathologic profile of advanced thyroid cancer to expedite effective targeted therapy and improve patient outcomes.
Our group has expertise in translational research as well as clinical experience in endocrine cancer. We already have a strategic pipeline of research across the spectrum of thyroid cancer with many projects involving junior scientists and clinicians.
Research goals
- Accelerate translation of research outcomes in diagnostics of thyroid cancer.
- Improve patient knowledge and experience.
- Foster collaboration with to ensure individualised treatment for patients is achieved.
- Cultivate pipeline of emerging researchers and experts.
Our current research projects include analysis of ctDNA, tailoring radioactive iodine therapy, risk stratification of thyroid nodules, machine learning models, pathological grading of endocrine cancers, utility of DOTATE-PET scans in thyroid cancer diagnosis.
With your help, our translational research can be accelerated and improve the quality of life and survival outcomes for patients with thyroid cancer.
If you are considering making a major gift or leaving a gift in will for our research, please contact one of our development professionals who will be able to discuss how you can give and the impact your gift could have.
Our people
2022
- Thyroid: A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes
- Thyroid: Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy
- Thyroid: Factors That Inform Individual Decision Making Between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review
- Annals of Surgical Oncology: ASO Author Reflections: Medullary Thyroid Cancer - Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape
- Annals of Surgical Oncology: Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy
- Clinical Endocrinology: I-PET score: Combining whole body iodine and 18 F-FDG PET/CT imaging to predict progression in structurally or biochemically incomplete thyroid cancer
- World Journal of Surgery: The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma
- Journal of Clinical Oncology: International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
- ANZ Journal of Surgery: Thyroidectomy in Australia 2022: lessons from 21,000 consecutive cases
- The Journal of Clinical Endocrinology & Metabolism: Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
- Dr Matti Gild (Senior Lecturer in Medicine) is the chair of the group
- Assistant Professor Roderick Clifton-Bligh
- Assistant Professor Anthony Glover
- Dr Venessa Tsang
- Professor Bruce Robinson
- Professor Anthony Gill
- Dr Martyn Bullock
- Ms Rhonda Siddall
- Ms Yue Zhao
- Assistant Professor Angela Chou
- Dr Ayanthi Wijewardene
- Dr John Turchini
- Dr Lyndal Tacon
- Dr Mahsa Ahadi
- Assistant Professor Mark Sywak
- Professor Stan Sidhu
- Assistant Professor Tom Eade
- Ms Pip Coomes
We collaborate with many other colleagues across NSW including paediatrics, implementation science and oncology. Contact us to find out more.
- Dr Eleanor White
- Dr Jessica Bindra
- Dr Sumathy Perampalam
- Dr Linh Nguyen
If you're a PhD, Honours or Masters student and are interested in our work, contact our Research Chair, Dr Matti Gild for how you can get involved.
- Discovery of molecular therapeutic targets in PDTC
- Liquid biopsy optimisation techniques and clinical applications in thyroid cancer
- Royal Australasian College of Surgeons (RACS) John Mitchell Crouch Fellowship: "Improving outcomes for patients with advanced thyroid cancer"
- Ramsay Research Trust Fund
- Ramsay Research Trust Fund: "Clinical utility of serum thyroglobulin analysis by mass spectrometry in thyroid cancer"
- Royal College of Pathologists Australia (RCPA) Grant-in-Aid: "Clinical utility of serum thyroglobulin analysis by mass spectrometry in thyroid cancer"
- Endocrine Society of Australia (ESA) Research Seed Grant